Autopsy report · NCT03363022

To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure

“Lack of Funds”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Institute of Liver and Biliary Sciences, India

Sponsor type

University, hospital or other

Conditions

Acute Liver Failure

Interventions

Standard Medical Treatment; Fecal Microbiota Transplant; Placebo

Participants

0

Sites

1

Countries

India

Trials that died the same way

• Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19
  “Lack of funding” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.